NCT04445090View on ClinicalTrials.gov

A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood

PHASE1TerminatedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 21, 2020

Primary Completion Date

September 10, 2021

Study Completion Date

September 10, 2021

Conditions
Healthy
Interventions
DRUG

BI 1569912

BI 1569912

DRUG

Placebo

Placebo

Trial Locations (1)

10117

Charité - Universitätsmedizin Berlin, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04445090 - A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood | Biotech Hunter | Biotech Hunter